Qiagen NV (United States) is listed on the Nasdaq and has a market capitalization of $8.56 billion, with shareholders equity totaling $3.33 billion.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Qiagen NV reported $2.10 billion in revenue, generating net income of $402.16 million.
Key financial metrics include a P/E ratio of 21.29, a price-to-book (P/B) ratio of 2.57, and a trailing twelve-month dividend yield of 5.54%.
The company trades under the ticker QGEN.